These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4885382)

  • 1. [Consideration on the evaluation of the immunizing power of BCG].
    Panisset M
    Bull Int Union Tuberc; 1968 Dec; 41():31-5. PubMed ID: 4885382
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
    Lugosi L
    Dev Biol Stand; 1992; 77():211-5. PubMed ID: 1426664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of 5 BCG substranins. I. Residual virulence of the French, Soviet, Swedish, Japanese and Rumanian substrains.
    Gheorghiu M; Paraschiveso M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):531-9. PubMed ID: 4923821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of culture conditions (oxygenation) on growth and morphology of BCG-Brazil and BCG-Glaxo vaccines].
    Feitosa JG; Gontijo Filho PP
    An Microbiol (Rio J); 1982; 27():69-79. PubMed ID: 6765360
    [No Abstract]   [Full Text] [Related]  

  • 5. [Susceptibility of mice from various lines to vaccine strains of mycobacterium tuberculosis (BCG)].
    Leshchinskaia EN; Nesterenko LA
    Probl Tuberk; 1971; 49(6):85-7. PubMed ID: 4940644
    [No Abstract]   [Full Text] [Related]  

  • 6. An interlaboratory comparative assay of viability and heat stability control of different BCG vaccines on two solid culture media.
    Suire A; Gheorghiu M
    Dev Biol Stand; 1986; 58 ( Pt A)():155-62. PubMed ID: 3297861
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardization of BCG multiple puncture 40 mg and BCG live (intravesical) Theracys/BCG therapeutic Immucyst.
    Csizer Z; Herbert A; Guest N; Sparkes J; Barreto L; Harjee N; Langlois S
    Dev Biol Stand; 1992; 77():223-7. PubMed ID: 1426666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiplication of lyophilized BCG in the body of the white mouse].
    Drăghici D; Sturdza SA; Gheorghiu M; Iliescu A
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):745-8. PubMed ID: 4939334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of the biological activity of BCG substrains].
    Rozenberg AM
    Probl Tuberk; 1971; 49(6):80-5. PubMed ID: 4940643
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tuberculosis vaccination--knowledge, experience and perspectives].
    Ganguin HG; Mydlak G; Zureck A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(1):101-39. PubMed ID: 4899216
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term stability of BCG vaccine sealed in ampoules under nitrogen with reference to its short-term heat resistance.
    Freudenstein H
    Dev Biol Stand; 1986; 58 ( Pt A)():133-7. PubMed ID: 3297859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of passaging in liquid media and storage on Mycobacterium bovis--BCG growth capacity and infectivity.
    Nascimento IP; Leite LC
    FEMS Microbiol Lett; 2005 Feb; 243(1):81-6. PubMed ID: 15668004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of the Hungarian National BCG Reference Preparations. Trend of viability during 4-7 years storage at +4 degrees C.
    Lugosi L
    Acta Microbiol Hung; 1987; 34(1):11-8. PubMed ID: 3307276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sealing of lyophilized BCG in argon and its advantages].
    Sturdza SA; Gheorghiu M; Rîmniceanu I
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):57-65. PubMed ID: 4936245
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of a BCG population with increased freeze-drying resistance.
    Stavri D; Stavri H; Drăghici D
    Dev Biol Stand; 1986; 58 ( Pt A)():139-44. PubMed ID: 3297860
    [No Abstract]   [Full Text] [Related]  

  • 16. Historical review of BCG vaccine in Japan.
    Yamamoto S; Yamamoto T
    Jpn J Infect Dis; 2007 Nov; 60(6):331-6. PubMed ID: 18032829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusions and recommendations arising out of a W.H.O. informal consultation on 'The choice of a BCG strain' for the production of freeze-dried vaccine. Bilthoven, 10 March 1976.
    J Biol Stand; 1977; 5(2):83-4. PubMed ID: 328508
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005.
    Knezevic I; Corbel MJ
    Vaccine; 2006 May; 24(18):3874-7. PubMed ID: 16755681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.